Trends in incidence, diagnosis, treatment and survival of hepatocellular carcinoma in a low-incidence country

Autor: Reinders, M.T.M., Meer, S. van, Burgmans, M.C., Jong, K.P. de, Klumpen, H.J., Man, R.A. de, Ramsoekh, D., Sprengers, D., Tjwa, E.T.T.L., Vos-Geelen, J. de, Erpecum, K.J. van, Geest, L.G.M. van der, Dutch Hepatocellular & Cholangioca

Publikováno v: European Journal of Cancer, 137, 214-223
European Journal of Cancer, 137, 214-223. ELSEVIER SCI LTD
European Journal of Cancer, 137, 214-223. Elsevier Limited
European Journal of Cancer, 137, 214-223. Elsevier Ltd.
European Journal of Cancer, 137, 214-223. Pergamon
European Journal of Cancer, 137, pp. 214-223
Reinders, M T M, van Meer, S, Burgmans, M C, de Jong, K P, Klümpen, H J, de Man, R A, Ramsoekh, D, Sprengers, D, Tjwa, E T T L, de Vos-Geelen, J, van Erpecum, K J, van der Geest, L G M & Dutch Hepatocellular & Cholangiocarcinoma Group (DHCG) 2020, ' Trends in incidence, diagnosis, treatment and survival of hepatocellular carcinoma in a low-incidence country : Data from the Netherlands in the period 2009–2016 ', European Journal of Cancer, vol. 137, pp. 214-223 . https://doi.org/10.1016/j.ejca.2020.07.008

Objective: Evaluation of the trends in incidence, diagnostics, treatment and survival of patients with hepatocellular carcinoma (HCC) in the Netherlands.Method: Data regarding incidence, diagnostics, primary treatment and survival of patients with HC

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a18b26de8d96d0dcc79c422d28d0004c
https://research.rug.nl/en/publications/451721d1-390e-453f-828f-1d6e126ec30f